We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleRandomised clinical trial: comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma.AuthorsShiah, H-S; Chen, C-Y; Dai, C-Y; Hsiao, C-F; Lin, Y-J; Su, W-C; Chang, J-Y; Whang-Peng, J; Lin, P-W; Huang, J-D; Chen, L-TAbstractDeregulation of mammalian target of rapamycin (mTOR) signalling is common in human hepatocellular carcinoma (HCC).PublicationAlimentary pharmacology & therapeutics, 2013, Vol 37, Issue 1, p62ISSN1365-2036Publication typeJournal ArticleDOI10.1111/apt.12132